These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 19515335)
1. [Beta-blockers or prostaglandins: which is the better choice?]. Denis P J Fr Ophtalmol; 2009 Mar; 32(3):206-11. PubMed ID: 19515335 [TBL] [Abstract][Full Text] [Related]
2. [New medical treatments of glaucoma. New strategies?]. Renard JP; May F; Rigal-Sastourne JC; Maurin JF J Fr Ophtalmol; 2001 Dec; 24(10):1095-9. PubMed ID: 11913242 [TBL] [Abstract][Full Text] [Related]
3. [The present role of prostaglandin analogues in the medical treatment of glaucoma]. Wierzbowska J; Rekas M; Malawko D Klin Oczna; 2005; 107(4-6):312-5. PubMed ID: 16118947 [TBL] [Abstract][Full Text] [Related]
4. Persistence and adherence with topical glaucoma therapy. Nordstrom BL; Friedman DS; Mozaffari E; Quigley HA; Walker AM Am J Ophthalmol; 2005 Oct; 140(4):598-606. PubMed ID: 16226511 [TBL] [Abstract][Full Text] [Related]
5. [Pharmacology aspects of glaucoma]. Alm A; Berggren L Nord Med; 1992; 107(12):306-8, 318. PubMed ID: 1361228 [TBL] [Abstract][Full Text] [Related]
6. Topical therapies for glaucoma: what family physicians need to know. Lewis PR; Phillips TG; Sassani JW Am Fam Physician; 1999 Apr; 59(7):1871-9, 1882. PubMed ID: 10208706 [TBL] [Abstract][Full Text] [Related]
7. Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices. Pajic B; Curr Med Res Opin; 2003; 19(2):95-101. PubMed ID: 12740152 [TBL] [Abstract][Full Text] [Related]
8. Persistency with medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994-2005. Owen CG; Carey IM; de Wilde S; Whincup PH; Wormald R; Cook DG Eye (Lond); 2009 May; 23(5):1098-110. PubMed ID: 18617908 [TBL] [Abstract][Full Text] [Related]
9. [Medical treatment of glaucoma]. García Sánchez J; García Feijoó J Arch Soc Esp Oftalmol; 2000 Jan; 75(1):11-20. PubMed ID: 11151107 [TBL] [Abstract][Full Text] [Related]
15. The rising cost of glaucoma drugs in Ireland 1996-2003. Knox FA; Barry M; McGowan B; O'Brien C Br J Ophthalmol; 2006 Feb; 90(2):162-5. PubMed ID: 16424526 [TBL] [Abstract][Full Text] [Related]
16. [Ocular side effects of glaucoma treatment agents]. Ehongo A; Bremer F Bull Soc Belge Ophtalmol; 2007; (304):103-10. PubMed ID: 17718234 [TBL] [Abstract][Full Text] [Related]
17. Switching within glaucoma medication class. Law SK Curr Opin Ophthalmol; 2009 Mar; 20(2):110-5. PubMed ID: 19240542 [TBL] [Abstract][Full Text] [Related]
18. [Medical treatments and practices. What should be done when a prostaglandin proves ineffective?]. Nordmann JP J Fr Ophtalmol; 2005 Jun; 28 Spec No 2():2S41-2S44. PubMed ID: 16208240 [TBL] [Abstract][Full Text] [Related]
19. Switch to latanoprost monotherapy from combined treatment with beta-antagonist and other antiglaucoma agents in patients with glaucoma or ocular hypertension. Ito K; Goto R; Matsunaga K; Sugimoto K; Uji Y Jpn J Ophthalmol; 2004; 48(3):276-80. PubMed ID: 15175922 [TBL] [Abstract][Full Text] [Related]